Figure 2From: Comparison of predicted susceptibility between genotype and virtual phenotype HIV drug resistance interpretation systems among treatment-naive HIV-infected patients in Asia: TASER-M cohort analysis Number and percentage of major and minor discrepancies for each ARV– 3-level interpretation, excluding efavirenz, nevirapine and emtricitabine. Back to article page